MedTrace Logo

Evaluation of FES+VFBT With Individuals With Lived Experience

NCT05744271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-03-19

No results posted yet for this study

Summary

Falls are a concern for people living with spinal cord injury (SCI) or stroke. Falls may result in injury and a fear of falling, which often cause people to restrict their mobility and daily activities. Despite its importance, fall prevention for people with SCI or stroke has not been studied in detail, and as a result, there is a lack of treatments to address their high fall risk.

Functional electrical stimulation (FES) is the application of a mild electrical stimulus to a muscle that helps it move better. In this study, the MyndSearch device will be used to deliver FES. The visual feedback balance training (VFBT) is similar to playing a video game on a balance board while following visual cues on a screen.

The purpose of this study is to evaluate an intervention that combines FES and VFBT to improve balance and lead to the recovery of safe mobility in individuals living with neurological disease or injury (e.g., spinal cord injury, stroke).

Conditions

Interventions

DEVICE

FES+VFBT

Standing balance training with the FES+VFBT system will occur 3x/week for six weeks (i.e. 18 sessions). Electrodes will be placed on the participants' plantarflexors and dorsiflexors bilaterally and FES will be administered using the device, MyndSearch, during the balance training exercises. Each session will last one hour, including 5 min to identify motor thresholds and maximum tolerable stimulation levels, 2 min to don/doff the safety harness, 5 min to calibrate the FES+VFBT exercises, up to 48 min to complete the FES+VFBT exercises. Rest breaks will be taken as needed.

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Kristin E Musselman, PhD · KITE-Toronto Rehabilitation Institute, UHN

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-05-22
Completion
2025-05-22

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05744271 on ClinicalTrials.gov